Company · Princeton, New Jersey, United States
Bionpharma Inc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 2
- 2 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 3
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| IBUPROFEN CAPSULES, 200MG | 02355116 | Approved | |
| IBUPROFEN CAPSULES, 400MG | 02332981 | Dormant |
Notices of Compliance
Newest first.
- IBUPROFEN CAPSULES, 200MGMay 23, 2025 · NOC 35406 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IBUPROFEN CAPSULES, 200 MGMay 7, 2020 · NOC 23563 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IBUPROFEN CAPSULES, 200 MG; IBUPROFEN CAPSULES, 400 MGDecember 14, 2016 · NOC 18768 · Abbreviated New Drug Submission (ANDS)